Besides, an elevated level of ROS that could be eliminated by antioxidative systems covering glutathione (GSH) and nuclear factor erythroid 2-related factor 2 (Nrf2) (14), is observed in cancer cells compared with that of normal cells. Here, NFE2L2 is linked to cancer.